Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Tables)

v3.19.1
10. SEGMENTS (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Summarized segment financial information
Three Months Ended March 31, 2019
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 1,343,983     $ 2,148,898     $ 35,708     $ 3,528,589  
                                 
Cost of product revenue     7,940,346       1,464,833       —         9,405,179  
                                 
(Loss) income from operations     (10,620,807 )     29,579       (2,617,188 )     (13,208,416 )
                                 
Interest and other (expense) income, net     (169,613 )     13,620       (1,268,472 )     (1,424,465 )
                                 
Gain on transfer of plasma center assets     —         11,527,421       —         11,527,421  
                                 
Loss on extinguishment of debt     —         —         (9,962,495 )     (9,962,495 )
                                 
Net (loss) income     (10,790,420 )     11,570,620       (13,848,155 )     (13,067,955 )
                                 
Capital expenditures     110,453       —         —         110,453  
                                 
Depreciation and amortization expense     687,393       114,241       3,696       805,330  
                                 
Total assets     57,529,070       4,038,367       16,552,533       78,119,970  

 

Three Months Ended March 31, 2018
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 1,666,243     $ 2,340,055     $ 35,708     $ 4,042,006  
                                 
Cost of product revenue     10,697,642       1,545,106       —         12,242,748  
                                 
Loss from operations     (12,724,718 )     (1,038,824 )     (2,768,961 )     (16,532,503 )
                                 
Interest and other expense, net     (240,054 )     (435 )     (1,049,150 )     (1,289,639 )
                                 
Net loss     (12,964,772 )     (1,039,259 )     (3,818,111 )     (17,822,142 )
                                 
Total assets     47,481,781       27,532,613       16,123,231       91,137,625  
                                 
Depreciation and amortization expense     631,832       188,914       8,795       829,541  
                                 
Capital expenditures     105,199       444,047       —         549,246